ES2027728T3 - Procedimiento para hacer un injerto que se ha de usar para actila cicatrizacion de un tejido. - Google Patents

Procedimiento para hacer un injerto que se ha de usar para actila cicatrizacion de un tejido.

Info

Publication number
ES2027728T3
ES2027728T3 ES198888109803T ES88109803T ES2027728T3 ES 2027728 T3 ES2027728 T3 ES 2027728T3 ES 198888109803 T ES198888109803 T ES 198888109803T ES 88109803 T ES88109803 T ES 88109803T ES 2027728 T3 ES2027728 T3 ES 2027728T3
Authority
ES
Spain
Prior art keywords
tissue
healing
actile
graft
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198888109803T
Other languages
English (en)
Inventor
Bert L. Vallee
Thomas V. King
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Harvard College
Original Assignee
Harvard College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/064,215 external-priority patent/US4952404A/en
Application filed by Harvard College filed Critical Harvard College
Application granted granted Critical
Publication of ES2027728T3 publication Critical patent/ES2027728T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1891—Angiogenesic factors; Angiogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/80—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special chemical form
    • A61L2300/802—Additives, excipients, e.g. cyclodextrins, fatty acids, surfactants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Vascular Medicine (AREA)
  • Neurosurgery (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)

Abstract

LA CICATRIZACION DE UN TEJIDO AVASCULAR HERIDO, SE PROMUEVE APLICANDO UN FACTOR ANGIOGENICO EN LA PROXIMIDAD DEL TEJIDO HERIDO EN FORMA DE UNA IMPLANTACION.
ES198888109803T 1987-06-19 1988-06-20 Procedimiento para hacer un injerto que se ha de usar para actila cicatrizacion de un tejido. Expired - Lifetime ES2027728T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/064,215 US4952404A (en) 1987-06-19 1987-06-19 Promotion of healing of meniscal tissue
US07/204,097 US4952403A (en) 1987-06-19 1988-06-08 Implants for the promotion of healing of meniscal tissue

Publications (1)

Publication Number Publication Date
ES2027728T3 true ES2027728T3 (es) 1992-06-16

Family

ID=26744280

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198888109803T Expired - Lifetime ES2027728T3 (es) 1987-06-19 1988-06-20 Procedimiento para hacer un injerto que se ha de usar para actila cicatrizacion de un tejido.

Country Status (11)

Country Link
US (1) US4952403A (es)
EP (1) EP0295721B1 (es)
JP (1) JPS6486974A (es)
KR (1) KR910005886B1 (es)
AU (1) AU605599B2 (es)
CA (1) CA1326817C (es)
DE (1) DE3867328D1 (es)
DK (1) DK333788A (es)
ES (1) ES2027728T3 (es)
GR (1) GR3004229T3 (es)
PT (1) PT87753B (es)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0476045B1 (en) * 1989-06-05 1996-08-28 Massachusetts Institute Of Technology Bioerodible polymers for drug delivery in bone
US7196054B1 (en) 1990-11-27 2007-03-27 The American National Red Cross Methods for treating wound tissue and forming a supplemented fibrin matrix
US6117425A (en) * 1990-11-27 2000-09-12 The American National Red Cross Supplemented and unsupplemented tissue sealants, method of their production and use
CA2097063C (en) * 1990-11-27 2006-08-08 Howard P. Greisler Tissue sealant and growth factor containing compositions that promote accelerated wound healing
US6197325B1 (en) 1990-11-27 2001-03-06 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
US6054122A (en) * 1990-11-27 2000-04-25 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
US6559119B1 (en) 1990-11-27 2003-05-06 Loyola University Of Chicago Method of preparing a tissue sealant-treated biomedical material
US5206023A (en) * 1991-01-31 1993-04-27 Robert F. Shaw Method and compositions for the treatment and repair of defects or lesions in cartilage
US5326568A (en) * 1991-05-03 1994-07-05 Giampapa Vincent C Method of tissue-specific delivery
US5201728A (en) * 1991-05-03 1993-04-13 Giampapa Vincent C Subcutaneous implantable multiple-agent delivery system
CA2071137A1 (en) * 1991-07-10 1993-01-11 Clarence C. Lee Composition and method for revitalizing scar tissue
US5270300A (en) * 1991-09-06 1993-12-14 Robert Francis Shaw Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone
USRE38827E1 (en) 1994-07-27 2005-10-11 3M Innovative Properties Company Adhesive sealant composition
US5583114A (en) 1994-07-27 1996-12-10 Minnesota Mining And Manufacturing Company Adhesive sealant composition
US5660848A (en) * 1994-11-02 1997-08-26 The Population Council, Center For Biomedical Research Subdermally implantable device
US6107102A (en) * 1995-06-07 2000-08-22 Regents Of The University Of California Therapeutic microdevices and methods of making and using same
US6762336B1 (en) 1998-01-19 2004-07-13 The American National Red Cross Hemostatic sandwich bandage
DE19841698A1 (de) * 1998-09-11 2000-03-16 Curative Technologies Gmbh Wachstumsfaktor-enthaltende Zusammensetzung zur Heilung von Gewebeschäden
US6964685B2 (en) 1999-06-22 2005-11-15 The Brigham And Women's Hospital, Inc. Biologic replacement for fibrin clot
AU5754800A (en) * 1999-06-22 2001-01-09 Brigham And Women's Hospital Biologic replacement for fibrin clot for intra-articular use
US20040018228A1 (en) * 2000-11-06 2004-01-29 Afmedica, Inc. Compositions and methods for reducing scar tissue formation
US20040241211A9 (en) * 2000-11-06 2004-12-02 Fischell Robert E. Devices and methods for reducing scar tissue formation
US6534693B2 (en) * 2000-11-06 2003-03-18 Afmedica, Inc. Surgically implanted devices having reduced scar tissue formation
US6648911B1 (en) 2000-11-20 2003-11-18 Avantec Vascular Corporation Method and device for the treatment of vulnerable tissue site
GB0113697D0 (en) 2001-06-06 2001-07-25 Smith & Nephew Fixation devices for tissue repair
AU2003270401B2 (en) 2002-09-10 2008-03-13 American National Red Cross Hemostatic dressing
ES2396689T3 (es) 2003-12-11 2013-02-25 Isto Technologies Inc. Sistema de cartílago particulado
CA2575988C (en) 2004-08-04 2014-02-18 Brookwood Pharmaceuticals, Inc. Methods for manufacturing delivery devices and devices thereof
WO2007025290A2 (en) 2005-08-26 2007-03-01 Isto Technologies, Inc. Implants and methods for repair, replacement and treatment of joint disease
EP1981435A2 (en) 2006-01-25 2008-10-22 Children's Medical Center Corporation Methods and procedures for ligament repair
NZ574653A (en) * 2006-08-04 2012-11-30 Stb Lifesaving Technologies Inc Solid dressing for treating wounded tissue
WO2008060361A2 (en) 2006-09-28 2008-05-22 Children's Medical Center Corporation Methods and collagen products for tissue repair
US8163549B2 (en) 2006-12-20 2012-04-24 Zimmer Orthobiologics, Inc. Method of obtaining viable small tissue particles and use for tissue repair
WO2008128075A1 (en) 2007-04-12 2008-10-23 Isto Technologies, Inc. Compositions and methods for tissue repair
WO2009020612A1 (en) * 2007-08-06 2009-02-12 Stb Lifesaving Technologies, Inc. Methods and dressing for sealing internal injuries
US8728528B2 (en) 2007-12-20 2014-05-20 Evonik Corporation Process for preparing microparticles having a low residual solvent volume
US11484578B2 (en) 2012-02-01 2022-11-01 Children's Medical Center Corporation Biomaterial for articular cartilage maintenance and treatment of arthritis
US20140178343A1 (en) 2012-12-21 2014-06-26 Jian Q. Yao Supports and methods for promoting integration of cartilage tissue explants
EP3798226A1 (en) 2013-02-01 2021-03-31 Children's Medical Center Corporation Collagen scaffolds

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4450150A (en) * 1973-05-17 1984-05-22 Arthur D. Little, Inc. Biodegradable, implantable drug delivery depots, and method for preparing and using the same
US4391797A (en) * 1977-01-05 1983-07-05 The Children's Hospital Medical Center Systems for the controlled release of macromolecules
SE416175B (sv) * 1979-03-07 1980-12-08 Per Ingvar Branemark For implantering i kroppsvevnad serskilt benvevnad, avsett material
US4529590A (en) * 1982-12-27 1985-07-16 Leveen Robert F Production of angiogenetic factor
US4503038A (en) * 1983-02-25 1985-03-05 The Regents Of The University Of California Extracellular nonmitogenic angiogenesis factor and method of isolation thereof from wound fluid
US4690682A (en) * 1983-04-15 1987-09-01 Damon Biotech, Inc. Sustained release
GB8330969D0 (en) * 1983-11-21 1983-12-29 Wellcome Found Promoting healing
IL74715A0 (en) * 1984-03-27 1985-06-30 Univ New Jersey Med Biodegradable matrix and methods for producing same
US4699788A (en) * 1984-08-20 1987-10-13 Trustees Of Boston University Angiogenic factor methods of extraction and method for producing angiogenesis
US4727137A (en) * 1985-04-17 1988-02-23 President And Fellows Of Harvard College Purified protein having angiogenic activity and methods of preparation
JPH0664019B2 (ja) * 1985-07-16 1994-08-22 株式会社日立製作所 画像表示処理装置
AU695983B3 (en) * 1997-09-19 1998-08-27 Badge Company (Proprietary) Limited, The Badge and method of making it

Also Published As

Publication number Publication date
PT87753A (pt) 1988-07-01
JPH0311785B2 (es) 1991-02-18
EP0295721B1 (en) 1992-01-02
GR3004229T3 (es) 1993-03-31
KR910005886B1 (ko) 1991-08-06
AU1811788A (en) 1988-12-22
PT87753B (pt) 1992-10-30
DK333788A (da) 1989-02-10
DE3867328D1 (de) 1992-02-13
JPS6486974A (en) 1989-03-31
KR890000101A (ko) 1989-03-11
DK333788D0 (da) 1988-06-17
AU605599B2 (en) 1991-01-17
EP0295721A3 (en) 1989-02-01
CA1326817C (en) 1994-02-08
US4952403A (en) 1990-08-28
EP0295721A2 (en) 1988-12-21

Similar Documents

Publication Publication Date Title
ES2027728T3 (es) Procedimiento para hacer un injerto que se ha de usar para actila cicatrizacion de un tejido.
JPS6434361A (en) Kit used in treatment of femur disorder
SE8803486D0 (sv) Dosage form for treating cardiovascular diseases
ES2149252T3 (es) Protesis intraocular.
FI946004A (fi) Lääketieteellisessä toimenpiteessä käytettävä trombiiniverifraktio
ES2059537T3 (es) Metodo para purgar in vitro celulas tumorales residuales con la ayuda de celulas citotoxicas activadas por una linfocina.
ES2069219T3 (es) Formulacion adhesiva para mejorar la regeneracion de nervios lesionados y formulacion farmaceutica adhesiva correspondiente.
ES2058547T3 (es) Fuente organica de fluoruro.
ES492310A0 (es) Un procedimiento para la preparacion de nuevas 3-hidroxi-3- pirrolin-2, 5-dionas-4-sustituidas
ES2179096T3 (es) Utilizacion de la interleucina-12 para prevenir la reaccion del injerto contra el huesped.
AR022404A1 (es) Metodo y agentes para la terapia de radiacion mejorada
ES2044860T3 (es) Estables aductos con disolventes de z-1-(p-beta-di-metil-amino-etoxi-fenil)-1-(p-hidroxi-fenil)-2-fenil-but-1-eno.
ES2140430T3 (es) Procedimiento para aumentar el brillo del cabello y para reparar el cabello dañado por productos alcalinos.
SG30591G (en) Use of azelastin and glycerine ethers for the treatment of psoriasis
SE8604757L (sv) Intraalveolert implantat
SE8700969D0 (sv) Resorberbar protes
ATE343983T1 (de) Ophthalmologisches implantat
MX9301192A (es) Uso de interleuquina-10 para suprimir la enfermedad de injerto-versus-huesped.
ES511604A0 (es) "un procedimiento para la obtencion de un principio activo fibrinolitico vasal o vascular, quimicamente denominable "enzima angioquinasa"".
ES2091260T3 (es) Procedimiento para la preparacion de piridin-2,3-dicarboxilato dialquilico y derivados del mismo a partir de diclorosuccinato dialquilico.
ES2150902T3 (es) Procedimientos para potenciar la cicatrizacion de heridas y la reparacion de tejidos.
ES520218A0 (es) Un procedimiento para la preparacion de nuevos 2,3-diaril-5-halotiofenos.
MX9206135A (es) Metodos
ES2191206T3 (es) Nueva utilizacion de la creatina.
DE69937892D1 (de) Implantatmaterial

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 295721

Country of ref document: ES